Stocks
Intelligent OutlookAZN-
Intelligent Outlook
AZN-
Prev Close-
50D MA-
200D MA-
52W High-
Live Price
AZN 24H Rolling
0.000.00%0.00
Rolling: Last 24h | 5m
AZN
Asset Information
Company Profile
Company:AZN
Sector:Pharmaceuticals
Industry:Pharmaceuticals
Country:GB
Employees:94,300
IPO Date:1993-05-18
Website:www.astrazeneca.com/
Technicals & Growth
Market Cap:$251.55B
Shares O/S:3,099,869,055
52W High:$86.57
52W Low:$61.24
50D MA:$81.21
200D MA:$74.48
Financial Ratios
P/E Ratio:30.51
EPS:$2.66
Profit Margin:17.41%
ROE (TTM):21.00%
ROA (TTM):8.97%
Div. Per Share:$1.56
AZN
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Loading chart library...
Financial Data (Macrotrends)
Historical Data
Loading...